Page last updated: 2024-10-20

quinolinic acid and Chronic Disease

quinolinic acid has been researched along with Chronic Disease in 4 studies

Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.
quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"Elevated brain concentrations of the neurotoxin and NMDA receptor agonist quinolinic acid (QUIN) have been demonstrated in portacaval-shunted (PCS) rats, a chronic hepatic encephalopathy (HE) model."7.69Brain quinolinic acid in chronic experimental hepatic encephalopathy: effects of an exogenous ammonium acetate challenge. ( Bengtsson, F; Bergqvist, PB; Bugge, M; Heyes, MP, 1995)
"Plasma quinolinic acid levels were significantly increased by stage I encephalopathy in patients with acute liver failure and by stages II and III in patients with chronic liver failure."7.69The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. ( al-Mardini, H; Basile, AS; Harrison, P; Heyes, MP; Hughes, RD; Li, Y; Record, CO; Saito, K; Williams, R, 1995)
"Elevated brain concentrations of the neurotoxin and NMDA receptor agonist quinolinic acid (QUIN) have been demonstrated in portacaval-shunted (PCS) rats, a chronic hepatic encephalopathy (HE) model."3.69Brain quinolinic acid in chronic experimental hepatic encephalopathy: effects of an exogenous ammonium acetate challenge. ( Bengtsson, F; Bergqvist, PB; Bugge, M; Heyes, MP, 1995)
"Plasma quinolinic acid levels were significantly increased by stage I encephalopathy in patients with acute liver failure and by stages II and III in patients with chronic liver failure."3.69The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. ( al-Mardini, H; Basile, AS; Harrison, P; Heyes, MP; Hughes, RD; Li, Y; Record, CO; Saito, K; Williams, R, 1995)
" This stimulation induces indoleamine 2,3-dioxygenase (IDO), an enzyme that reduces the tryptophan bioavailability to synthesize serotonin."1.51Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats. ( Caso, JR; García-Bueno, B; Leza, JC; Madrigal, JLM; Martín-Hernández, D; Tendilla-Beltrán, H, 2019)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Joisten, N1
Ruas, JL1
Braidy, N1
Guillemin, GJ1
Zimmer, P1
Martín-Hernández, D1
Tendilla-Beltrán, H1
Madrigal, JLM1
García-Bueno, B1
Leza, JC1
Caso, JR1
Bergqvist, PB1
Heyes, MP2
Bugge, M1
Bengtsson, F1
Basile, AS1
Saito, K1
al-Mardini, H1
Record, CO1
Hughes, RD1
Harrison, P1
Williams, R1
Li, Y1

Reviews

1 review available for quinolinic acid and Chronic Disease

ArticleYear
The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?
    Trends in molecular medicine, 2021, Volume: 27, Issue:10

    Topics: Chronic Disease; Humans; Kynurenic Acid; Kynurenine; Quinolinic Acid; Tryptophan

2021

Other Studies

3 other studies available for quinolinic acid and Chronic Disease

ArticleYear
Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
    Molecular neurobiology, 2019, Volume: 56, Issue:1

    Topics: Animals; Antidepressive Agents; Chronic Disease; Cytokines; Frontal Lobe; Glutamate Plasma Membrane

2019
Brain quinolinic acid in chronic experimental hepatic encephalopathy: effects of an exogenous ammonium acetate challenge.
    Journal of neurochemistry, 1995, Volume: 65, Issue:5

    Topics: Acetates; Animals; Brain; Chronic Disease; Hepatic Encephalopathy; Male; Quinolinic Acid; Rats; Rats

1995
The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy.
    Gastroenterology, 1995, Volume: 108, Issue:3

    Topics: Acute Disease; Adult; Brain; Chronic Disease; Female; Hepatic Encephalopathy; Humans; Liver Failure;

1995